There are 3 billion base pairs in our human genome. Surprisingly, only 2% of such vast information codes for approximately 20,000 genes, which encode for proteins—the basic building blocks of cells1. The remaining 98% of the human genome, sometimes referred to as the dark side of the human genome, contains many non-coding regulatory elements (NCREs), which control the combinational expression of the limited number of genes to form diverse cell types and tissues of a complex human body, all from the same copy of the genome. Although we have learned a lot about the biology of many different NCREs, our knowledge of silencers—one of the important categories of NCRE—is surprisingly limited. Furthermore, over the past decades, the pharmaceutical values of targeting genes/proteins to treat diseases have been extensively exploited, leading to many successful drugs. However, the therapeutic potential of 98% of the non-coding human genome, especially the silencers, has not been unlocked. Such limitation is not only because of the large size of the non-coding genome, but also the lack of functional understanding of NCREs in different tissues and contexts. In the project Silencer, I aim to identify silencers in the human genome in an unbiased fashion. I expect that there are many silencers present in the human genome with unique signatures. And these silencers will play important roles in normal physiology, tissue development and disease onset.